Akso Health Group ADR
$ 1.35
2.28%
07 Aug - close price
- Market Cap 1,156,636,000 USD
- Current Price $ 1.35
- High / Low $ 1.45 / 1.25
- Stock P/E N/A
- Book Value 0.21
- EPS -0.03
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.10 %
- 52 Week High 2.50
- 52 Week Low 1.10
About
Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.
Analyst Target Price
N/A
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-10 | 2025-11-13 | 2025-08-14 | 2025-06-17 | 2025-03-28 | 2024-07-12 | 2024-04-29 | 2024-01-11 | 2023-12-18 | 2023-07-14 | 2023-06-20 | 2023-02-16 |
| Reported EPS | 0 | 0 | -0.4 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | 0 | 0 | -0.4 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.4 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AHG
2026-08-07 00:11:09
This article provides an earnings forecast for Akso Health Group (AHG), focusing on future EPS and revenue growth estimates. It includes a current stock quote, market capitalization, and a list of peer companies for comparison. The data was updated on August 8, 2026.
2026-08-04 12:40:19
This article provides an overview of Akso Health Group (AHG:UR), including its stock price, quote, and related news. It appears to be a stub or placeholder page from BNN Bloomberg, indicating that more detailed financial information and news about the company would typically be found here.
2026-07-31 08:11:28
Akso Health Group (AHG) has a weak financial score of 5.22, ranking 470 out of 485 in its industry, indicating low operating efficiency. Despite this, its latest quarterly revenue saw a significant 676.00% year-over-year increase, and net profit rose by 83.03% year-over-year. However, several key financial data points regarding quality of earnings, operational efficiency, growth potential, and shareholder returns have not yet been disclosed by the company.
2026-07-31 06:09:55
Akso Health Group (AHG) saw an 8.2% stock price increase despite its auditor, CHI-LLTC, issuing a "going concern" warning. This warning highlights substantial doubt about the company's financial resilience, even though it reported narrower losses for the period ended March 31, 2026, with sales of US$13.84 million and a net loss of US$18.67 million. The auditor's concern focuses on the company's ability to sustain itself given its limited revenue, early-stage brain-computer interface ambitions, and historical reliance on equity issuance for funding.
2026-07-30 07:12:12
Akso Health Group (AHG) has a current valuation score of 8.45, ranking 161 out of 485 in the Software & IT Services industry. Its P/E ratio is -3.32, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
2026-07-28 07:20:20
Akso Health Group (AHG) has an institutional shareholding score of 3.00, placing it 283rd out of 485 companies in the Software & IT Services industry. The institutional shareholding proportion is 0.02%, representing a significant quarter-over-quarter decrease. James Simons is identified as the largest institutional shareholder, though his holdings have also decreased.
